Drug Profile


Alternative Names: IRFI 016

Latest Information Update: 04 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Biomedica Foscama
  • Class Benzofurans; Benzopyrans; Expectorants
  • Mechanism of Action Free radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Atherosclerosis; Diabetic complications

Most Recent Events

  • 25 Oct 2005 This compound is still in active development
  • 27 Jun 2001 Phase-II clinical trials for Atherosclerosis in Italy (PO)
  • 27 Jun 2001 Phase-II clinical trials for Atherosclerosis in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top